News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
484,773 Results
Type
Article (8030)
Company Profile (140)
Press Release (476506)
Multimedia
Podcasts (4)
Webinars (6)
Section
Business (166743)
Career Advice (304)
Deals (25738)
Drug Delivery (7)
Drug Development (52887)
Employer Resources (14)
FDA (9762)
Job Trends (8572)
News (238203)
Policy (17900)
Tag
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (3)
2027 Biotech Bay Standard (4)
2027 Genetown Elite (1)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (1)
Academia (487)
Accelerated approval (24)
ADA (18)
Adcomms (1)
Allergies (96)
Alliances (33158)
ALS (105)
Alzheimer's disease (975)
Antibody-drug conjugate (ADC) (263)
Approvals (10377)
Artificial intelligence (320)
ASCO (159)
Autoimmune disease (205)
Automation (28)
Bankruptcy (262)
Best Places to Work (6958)
BIO (36)
Biologics (2)
BIOSECURE Act (1)
Biosimilars (109)
BioSpace Insights (17)
Biotechnology (88)
Bladder cancer (138)
Brain cancer (29)
Breast cancer (508)
Cancer (3647)
Cardiovascular disease (217)
Career advice (245)
Career pathing (1)
CAR-T (172)
Celiac Disease (1)
Cell therapy (476)
Cervical cancer (34)
Clinical research (47875)
Collaboration (1245)
Commercialization (3)
Compensation (1468)
Complete response letters (34)
COVID-19 (759)
CRISPR (63)
C-suite (747)
Cystic fibrosis (85)
Data (5652)
Denatured (4)
Depression (102)
Dermatology (61)
Diabetes (343)
Diagnostics (4186)
Digital health (39)
Diversity (1)
Diversity, equity & inclusion (4)
Drug discovery (155)
Drug pricing (7)
Drug shortages (2)
Duchenne muscular dystrophy (163)
Earnings (73715)
Editorial (1)
Employer branding (2)
Employer resources (14)
Events (87611)
Executive appointments (701)
FDA (12389)
Fibrodysplasia Ossificans Progressiva (9)
Friedreich's ataxia (18)
Frontotemporal dementia (23)
Funding (919)
Gene editing (125)
Generative AI (9)
Gene therapy (318)
GLP-1 (290)
Government (944)
Grass and pollen (2)
Guidances (281)
Healthcare (9317)
Hematology (94)
HIV (52)
Huntington's disease (22)
IgA nephropathy (64)
Immunology and inflammation (98)
Immuno-oncology (56)
Indications (157)
Infectious disease (947)
Inflammatory bowel disease (126)
Inflation Reduction Act (4)
Influenza (84)
Intellectual property (255)
Interviews (41)
IPO (12387)
IRA (2)
Job creations (1968)
Job search strategy (235)
JPM (1)
Kidney cancer (16)
Layoffs (59)
Legal (5195)
Licensing (8)
Liver cancer (44)
Longevity (17)
Lung cancer (509)
Lymphoma (250)
Machine learning (27)
Management (3)
Manufacturing (534)
Marketing (8)
MASH (118)
Medical device (8655)
Medtech (8800)
Mergers & acquisitions (14383)
Metabolic disorders (706)
mRNA (55)
Multiple sclerosis (102)
NASH (4)
Neurodegenerative disease (220)
Neuropsychiatric disorders (39)
Neuroscience (1824)
NextGen: Class of 2026 (3150)
Non-profit (841)
Obesity (223)
Opinion (11)
Ovarian cancer (158)
Pain (172)
Pancreatic cancer (196)
Parkinson's disease (201)
Partnered (12)
Patents (476)
Patient recruitment (507)
Peanut (31)
People (41233)
Pharmaceutical (30)
Pharmacy benefit managers (8)
Phase 1 (15469)
Phase 2 (21382)
Phase 3 (14404)
Pipeline (7323)
Policy (18)
Postmarket research (1570)
Preclinical (6539)
Press Release (34)
Prostate cancer (189)
Psychedelics (7)
Radiopharmaceuticals (189)
Rare diseases (572)
Real estate (3019)
Recruiting (6)
Regulatory (14818)
Reports (21)
Research institute (581)
Resumes & cover letters (45)
Rett syndrome (41)
RNA editing (5)
RSV (48)
Schizophrenia (100)
Series A (156)
Series B (121)
Service/supplier (5)
Sickle cell disease (63)
Spinal muscular atrophy (88)
Sponsored (5)
Startups (2019)
Stomach cancer (3)
Supply chain (50)
Vaccines (323)
Venture capital (17)
Weight loss (73)
Women's health (79)
Date
Today (3)
Last 7 days (195)
Last 30 days (1538)
Last 365 days (18997)
2026 (12298)
2025 (19251)
2024 (22988)
2023 (26541)
2022 (34587)
2021 (37172)
2020 (33481)
2019 (23275)
2018 (17473)
2017 (18765)
2016 (17921)
2015 (24263)
2014 (21679)
2013 (18135)
2012 (20222)
2011 (20444)
2010 (20333)
Location
Africa (229)
Alabama (73)
Alaska (2)
Arizona (305)
Arkansas (11)
Asia (17893)
Australia (2099)
California (11966)
Canada (3147)
China (524)
Colorado (484)
Connecticut (409)
Delaware (208)
Europe (24630)
Florida (1789)
Georgia (380)
Hawaii (3)
Idaho (46)
Illinois (699)
India (51)
Indiana (314)
Iowa (15)
Japan (399)
Kansas (101)
Kentucky (30)
Louisiana (27)
Maine (26)
Maryland (1202)
Massachusetts (7852)
Michigan (307)
Minnesota (559)
Mississippi (4)
Missouri (82)
Montana (20)
Nebraska (11)
Nevada (116)
New Hampshire (60)
New Jersey (2620)
New Mexico (12)
New York (2822)
North Carolina (1278)
North Dakota (4)
Northern California (5993)
Ohio (278)
Oklahoma (14)
Oregon (16)
Pennsylvania (2253)
Puerto Rico (20)
Rhode Island (30)
South America (407)
South Carolina (76)
South Dakota (1)
Southern California (4971)
Tennessee (120)
Texas (1940)
United States (38861)
Utah (360)
Vermont (1)
Virginia (153)
Washington D.C. (38)
Washington State (928)
West Virginia (1)
Wisconsin (73)
Wyoming (1)
484,773 Results for "medicinova inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
MediciNova Announces Patient Enrollment Milestone Achieved in SEANOBI Study Expanded-Access-Program Evaluating MN‑166 (ibudilast) in ALS patients
July 15, 2026
·
6 min read
Press Releases
MediciNova to Participate at the 38th Annual ROTH Conference
March 16, 2026
·
4 min read
Press Releases
MediciNova Announces Completion of Last Patient Last Visit in the MN-001-NATG-202 Clinical Trial of MN-001 (Tipelukast)
May 26, 2026
·
6 min read
Press Releases
New Peer‑Reviewed Study Reveals Actionable Immune–Microenvironment Target in Brain Metastasis; Medicinova Advances Clinical Translation
April 28, 2026
·
6 min read
Press Releases
MediciNova Receives Notice of Allowance for New Patent Covering Use of MN-166 in Combination with Anti-PD-1 Immune Checkpoint Inhibitor for Glioblastoma Treatment
June 8, 2026
·
5 min read
Press Releases
MediciNova Announces 100 Patients Enrolled in SEANOBI Study Expanded-Access-Program (EAP) Evaluating MN‑166 (ibudilast) in ALS patients
January 30, 2026
·
7 min read
Press Releases
MediciNova Appoints Dr. Christopher Breder, MD, PhD as Clinical and Regulatory Advisor
November 18, 2025
·
5 min read
Press Releases
MediciNova Compounds Demonstrate Novel Therapeutic Approach for Atherosclerosis in Peer-Reviewed Publication
October 31, 2025
·
5 min read
Press Releases
MediciNova Wins Contract Research and Development Innovation Award at 2025 BioTech Breakthrough Awards
November 6, 2025
·
5 min read
Press Releases
MediciNova Achieves Enrollment in COMBAT-ALS Clinical Trial
August 26, 2025
·
5 min read
1 of 48,478
Next
